EA201500669A1 - Офтальмологическая фармацевтическая композиция для наружного применения, содержащая регорафениб - Google Patents
Офтальмологическая фармацевтическая композиция для наружного применения, содержащая регорафенибInfo
- Publication number
- EA201500669A1 EA201500669A1 EA201500669A EA201500669A EA201500669A1 EA 201500669 A1 EA201500669 A1 EA 201500669A1 EA 201500669 A EA201500669 A EA 201500669A EA 201500669 A EA201500669 A EA 201500669A EA 201500669 A1 EA201500669 A1 EA 201500669A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical composition
- regoraphenib
- ophthalmic pharmaceutical
- external application
- application containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Inorganic Chemistry (AREA)
Abstract
Представленное изобретение касается офтальмологической фармацевтической композиции для наружного применения, содержащей регорафениб, его гидрат, сольват или фармацевтически приемлемую соль или его полиморфную форму, но без гидрофобного диоксида кремния, и способа ее получения и ее применения для лечения офтальмологических расстройств.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12198892 | 2012-12-21 | ||
PCT/US2013/077358 WO2014100797A1 (en) | 2012-12-21 | 2013-12-21 | Topical ophthalmological pharmaceutical composition containing regorafenib |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201500669A1 true EA201500669A1 (ru) | 2015-12-30 |
Family
ID=47458742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201500669A EA201500669A1 (ru) | 2012-12-21 | 2013-12-21 | Офтальмологическая фармацевтическая композиция для наружного применения, содержащая регорафениб |
Country Status (27)
Country | Link |
---|---|
US (2) | US20140179745A1 (ru) |
EP (1) | EP2934481A1 (ru) |
JP (1) | JP2016507505A (ru) |
KR (1) | KR20150100670A (ru) |
CN (1) | CN104955443A (ru) |
AP (1) | AP2015008493A0 (ru) |
AR (1) | AR094104A1 (ru) |
AU (1) | AU2013364004A1 (ru) |
BR (1) | BR112015014078A2 (ru) |
CA (1) | CA2895804A1 (ru) |
CL (1) | CL2015001701A1 (ru) |
CR (1) | CR20150327A (ru) |
CU (1) | CU20150063A7 (ru) |
DO (1) | DOP2015000155A (ru) |
EA (1) | EA201500669A1 (ru) |
EC (1) | ECSP15026386A (ru) |
IL (1) | IL238791A0 (ru) |
MA (1) | MA38215A1 (ru) |
MX (1) | MX2015007488A (ru) |
PE (1) | PE20151784A1 (ru) |
PH (1) | PH12015501407A1 (ru) |
SG (1) | SG11201503838WA (ru) |
TN (1) | TN2015000280A1 (ru) |
TW (1) | TW201431568A (ru) |
UY (1) | UY35183A (ru) |
WO (1) | WO2014100797A1 (ru) |
ZA (1) | ZA201505196B (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190142738A1 (en) * | 2016-05-16 | 2019-05-16 | Delivra Inc. | Transdermal formulations for delivery of celecoxib and its use in the treatment of celecoxib-responsive diseases and conditions |
CN112834485B (zh) * | 2021-02-07 | 2022-03-29 | 西南交通大学 | 激光诱导击穿光谱元素定量分析的一种非定标方法 |
KR102413226B1 (ko) | 2021-08-26 | 2022-06-23 | 충북대학교 산학협력단 | 레고라페닙을 유효성분으로 포함하는 항노화 조성물 |
KR20230166353A (ko) | 2022-05-30 | 2023-12-07 | (주) 레비레스코 | 감태 추출물, 귤피 추출물, 및 녹차 추출물을 유효성분으로 포함하는 자외선에 대한 세포 보호용 또는 mmp-1 발현 억제용 조성물 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ580384A (en) | 2003-07-23 | 2011-03-31 | Bayer Pharmaceuticals Corp | 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions |
BRPI0609227A2 (pt) | 2005-05-10 | 2010-03-09 | Alcon Inc | composições de suspensão de nepafenac e outros fármacos oftálmicos, bem como uso das referidas composições no tratamento tópico de distúrbios oftálmicos |
NZ563984A (en) | 2005-06-08 | 2011-11-25 | Targegen Inc | Methods and compositions for the treatment of ocular disorders |
ES2350858T3 (es) | 2005-11-29 | 2011-01-27 | Glaxosmithkline Llc | Tratamiento de trastornos neovasculares oculares tales como degeneración macular, estrías angioides, uveitis y edema macular. |
JP2009519267A (ja) * | 2005-12-15 | 2009-05-14 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 炎症性の皮膚、眼および/または耳疾患を処置するためのジアリールウレア |
JP2009521493A (ja) | 2005-12-23 | 2009-06-04 | アルコン,インコーポレイテッド | 眼への受容体チロシンキナーゼ阻害(RTKi)化合物の送達のための医薬製剤 |
WO2008027341A2 (en) | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
AR062927A1 (es) | 2006-10-11 | 2008-12-17 | Bayer Healthcare Ag | 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada |
WO2010127029A1 (en) | 2009-05-01 | 2010-11-04 | Ophthotech Corporation | Methods for treating or preventing ophthalmological diseases |
MX2012000706A (es) | 2009-07-16 | 2012-06-01 | Glaxo Wellcome Mfg Pte Ltd | Metodo de tratamiento. |
WO2013000917A1 (en) * | 2011-06-28 | 2013-01-03 | Bayer Intellectual Property Gmbh | Topical ophthalmological pharmaceutical composition containing regorafenib |
-
2013
- 2013-12-11 UY UY0001035183A patent/UY35183A/es unknown
- 2013-12-16 US US14/106,883 patent/US20140179745A1/en not_active Abandoned
- 2013-12-18 AR ARP130104842A patent/AR094104A1/es unknown
- 2013-12-20 TW TW102147361A patent/TW201431568A/zh unknown
- 2013-12-21 JP JP2015549853A patent/JP2016507505A/ja active Pending
- 2013-12-21 PE PE2015000932A patent/PE20151784A1/es not_active Application Discontinuation
- 2013-12-21 BR BR112015014078A patent/BR112015014078A2/pt not_active IP Right Cessation
- 2013-12-21 AU AU2013364004A patent/AU2013364004A1/en not_active Abandoned
- 2013-12-21 CA CA2895804A patent/CA2895804A1/en not_active Abandoned
- 2013-12-21 KR KR1020157016128A patent/KR20150100670A/ko not_active Application Discontinuation
- 2013-12-21 MX MX2015007488A patent/MX2015007488A/es unknown
- 2013-12-21 AP AP2015008493A patent/AP2015008493A0/xx unknown
- 2013-12-21 US US14/653,317 patent/US20150328145A1/en not_active Abandoned
- 2013-12-21 SG SG11201503838WA patent/SG11201503838WA/en unknown
- 2013-12-21 CN CN201380067534.XA patent/CN104955443A/zh active Pending
- 2013-12-21 EA EA201500669A patent/EA201500669A1/ru unknown
- 2013-12-21 WO PCT/US2013/077358 patent/WO2014100797A1/en active Application Filing
- 2013-12-21 EP EP13826820.6A patent/EP2934481A1/en not_active Withdrawn
-
2015
- 2015-05-13 IL IL238791A patent/IL238791A0/en unknown
- 2015-06-17 CL CL2015001701A patent/CL2015001701A1/es unknown
- 2015-06-17 DO DO2015000155A patent/DOP2015000155A/es unknown
- 2015-06-17 CU CUP2015000063A patent/CU20150063A7/es unknown
- 2015-06-18 TN TNP2015000280A patent/TN2015000280A1/fr unknown
- 2015-06-18 PH PH12015501407A patent/PH12015501407A1/en unknown
- 2015-06-19 EC ECIEPI201526386A patent/ECSP15026386A/es unknown
- 2015-06-19 MA MA38215A patent/MA38215A1/fr unknown
- 2015-06-19 CR CR20150327A patent/CR20150327A/es unknown
- 2015-07-20 ZA ZA2015/05196A patent/ZA201505196B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2013364004A1 (en) | 2015-06-04 |
TW201431568A (zh) | 2014-08-16 |
ECSP15026386A (es) | 2016-01-29 |
IL238791A0 (en) | 2015-06-30 |
CA2895804A1 (en) | 2014-06-26 |
MX2015007488A (es) | 2015-09-04 |
CU20150063A7 (es) | 2015-11-27 |
UY35183A (es) | 2014-07-31 |
KR20150100670A (ko) | 2015-09-02 |
BR112015014078A2 (pt) | 2018-05-15 |
PH12015501407A1 (en) | 2015-09-07 |
AP2015008493A0 (en) | 2015-05-31 |
TN2015000280A1 (en) | 2016-10-03 |
WO2014100797A1 (en) | 2014-06-26 |
MA38215A1 (fr) | 2017-01-31 |
US20140179745A1 (en) | 2014-06-26 |
US20150328145A1 (en) | 2015-11-19 |
SG11201503838WA (en) | 2015-07-30 |
CL2015001701A1 (es) | 2015-10-16 |
AR094104A1 (es) | 2015-07-08 |
DOP2015000155A (es) | 2015-08-31 |
CR20150327A (es) | 2015-09-14 |
EP2934481A1 (en) | 2015-10-28 |
ZA201505196B (en) | 2017-11-29 |
CN104955443A (zh) | 2015-09-30 |
JP2016507505A (ja) | 2016-03-10 |
PE20151784A1 (es) | 2015-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201590520A1 (ru) | Фармацевтическая композиция с покрытием, содержащая регорафениб | |
EA201591591A1 (ru) | Соединения карбазола, применяемые в качестве ингибиторов бромодомена | |
EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
EA201500365A1 (ru) | Комбинация регорафениба и ацетилсалициловой кислоты для лечения рака | |
EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
EA202090860A1 (ru) | Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn | |
EA201691216A1 (ru) | Композиции линаклотида с замедленным высвобождением | |
EA201492287A1 (ru) | Дейтерированные производные руксолитиниба | |
EA201300034A1 (ru) | Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения | |
WO2013188273A8 (en) | Topical ophthalmological pharmaceutical composition containing axitinib | |
EA201400064A1 (ru) | Офтальмологическая фармацевтическая композиция для местного применения, которая содержит регорафениб | |
EA201590364A1 (ru) | Применение орвепитанта, его солей и кристаллических форм и композиций, его содержащих, для лечения зуда | |
EA201692300A1 (ru) | Производные карбоксамида | |
NZ737892A (en) | Muscarinic m1 receptor positive allosteric modulators | |
EA201591717A1 (ru) | Твердые формы гидрохлорида вемурафениба | |
NZ740587A (en) | Fluoroindole derivatives as muscarinic m1 receptor positive allosteric modulators | |
EA201500669A1 (ru) | Офтальмологическая фармацевтическая композиция для наружного применения, содержащая регорафениб | |
EA201691058A1 (ru) | Производные пирролопирролона и их применение для лечения заболеваний | |
WO2013188279A8 (en) | Topical ophthalmological pharmaceutical composition containing cediranib | |
EA201800565A1 (ru) | Композиция для лечения заболеваний уха, содержащая (+)-азасетрон | |
EA201400444A1 (ru) | Производные 2-оксопиперидинила | |
EA201501130A1 (ru) | Офтальмологическая фармацевтическая композиция | |
EA201790020A1 (ru) | Соединения, фармацевтические композиции и их применение при лечении нейродегенеративных заболеваний | |
EA201500446A1 (ru) | Фармацевтическая композиция для снижения уровня n-оксида триметиламина | |
EA201600411A1 (ru) | Производные пиперидина для применения при лечении или профилактики психиатрических и неврологических состояний |